OB-GYN Private Equity Consolidation: What Practice Owners Should Understand

Executive summary

Private equity can give an obstetrics and gynecology practice liquidity, operating support, capital for expansion, and a path to combine with other groups. A transaction can also transfer control over important business decisions, alter the way the practice bears financial risk, and turn part of a seller’s proceeds into an investment whose value depends on a later sale. The headline purchase multiple alone cannot capture that bargain.

The specialty has characteristics that attract consolidators: local groups are often fragmented, patient relationships as well as referral networks are built over years, as well as practices may include several revenue streams as well as locations. A platform investor may acquire a substantial group, then add practices, physicians, locations, as well as related services. The operating model is often described as a management services organization, or MSO, supporting a physician-owned professional entity. The names of the entities matter less than the actual allocation of authority, cash, liabilities, as well as exit rights in the contracts.

Owners should evaluate four linked questions. What is being sold and how is its value measured? What cash is certain at closing, as well as what is contingent or rolled into equity? Who controls clinical and business decisions after closing? What happens if the owner retires, leaves, becomes disabled, disagrees with management, or the investor sells? These questions call for coordinated legal, tax, accounting, as well as transaction advice from professionals representing the owners, not the buyer.

A platform’s projected growth is not the same as realized value. Add-on acquisitions can increase scale, but integration costs, debt, clinician turnover, payer terms, service-line economics, and governance can all change the expected result. Rollover equity can provide meaningful participation in a later sale, while also concentrating a seller’s investment in a less liquid enterprise over which the seller may have limited control. Treat it as a new investment decision, separate from the decision to sell the practice.

This paper explains the common structures and owner diligence priorities. It does not recommend that any practice sell, remain independent, or choose a particular buyer. The right outcome depends on the owners’ goals, practice economics, local market, state law, and the terms offered.

Key figures

Analysis

Why the specialty attracts consolidation

Consolidation is a way to assemble a larger organization from separate local businesses. Investors may see opportunities to centralize billing, recruiting, scheduling, compliance administration, purchasing, as well as technology. A multi-site organization may be able to invest in leadership and systems that a small partnership cannot easily afford. Buyers may also value the ability to add physicians, locations, as well as adjacent services to an established network. The existence of a strategic rationale does not prove that it will be achieved; each claimed benefit should be tied to a cost, owner, timetable, as well as measurable operating assumption.

OB-GYN practices are not interchangeable units. Obstetric call coverage, hospital relationships, geographic coverage, physician recruitment, and practice-specific payer arrangements can all shape operating results. A group with a strong local reputation may depend heavily on a few physicians or on informal relationships that do not transfer automatically with ownership. A buyer’s integration plan should therefore be assessed at the level of the actual practice and market, not solely through national market-size claims.

Published research documents private equity affiliation in women’s health and provides context for investment and consolidation, while leaving important limits in the available evidence. Studies identify transactions through available data and use differing definitions of affiliation, acquisition, as well as practice. Their historical counts cannot establish the value of a particular offer, the prevalence in a particular city, or the clinical as well as financial results of a proposed transaction. Owners should use market studies to frame questions, then rely on their own verified financial as well as operating data.

Platform and add-on structures

A platform is commonly the initial sizable practice or group used as the base for a larger organization. The investor may acquire a controlling interest, recapitalize the business, or fund an entity that will own or control management assets and contractual rights. The platform may then acquire add-on practices. In a typical narrative, the combined group grows revenue and earnings, gains administrative scale, and is sold later at a higher enterprise value. Each step entails execution risk and costs, and the sellers’ actual participation depends on transaction documents and capital structure.

Add-on transactions can bring a platform geographic reach, physician capacity, referral connections, or service lines. They can also introduce incompatible systems, uneven margins, lease obligations, different compensation arrangements, as well as local culture differences. The platform may finance acquisitions with debt, new equity, seller notes, or some combination. When owners hear an expected future valuation, they should ask whether the forecast accounts for purchase price paid for add-ons, integration expense, working capital, debt repayment, dilution, as well as transaction fees.

The platform seller and an add-on seller may receive different economics. The first group may receive a combination of cash and equity in the parent organization. A later add-on may be purchased at a different multiple, with less or no rollover, or under an earnout. The add-on’s physicians may have limited voting rights and different liquidity rights from platform founders. Owners should compare the defined unit of value and the rights attached to each security, instead of assume that all participants share proportionally in enterprise growth.

MSO arrangements and clinical entity boundaries

Many transactions use a management services organization to provide nonclinical services to a physician-owned professional entity. The professional entity may employ or contract with clinicians and bill for professional services, while the MSO provides staffing administration, facilities, technology, marketing, revenue-cycle support, and other services under a management services agreement. The MSO may be owned by the investor. This structure is often used in states where corporate practice of medicine rules restrict non-physician ownership or control of a medical practice.

The label “MSO” does not answer whether the arrangement is compliant or whether physicians retain meaningful clinical authority. The documents should specify which entity employs clinicians, controls clinical protocols, handles patient records, contracts with payers, owns equipment as well as real estate, as well as bears responsibility for professional liability. The management fee formula deserves close review: a fixed amount, cost-plus charge, percentage of collections, or other formula may affect the professional entity’s remaining cash. The agreement should state how fees are benchmarked, adjusted, audited, as well as disputed.

Owners should trace the cash path from collections through expenses, management fees, debt service, distributions, as well as reserves. Determine whether the MSO can set budgets, require spending, hire or dismiss administrative staff, or impose vendor contracts that constrain the clinical entity. Consider whether a fee obligation remains payable if collections fall, whether it is subordinated to clinical payroll as well as obligations, as well as what happens upon termination. State-specific counsel should assess the structure and documents; corporate practice and fee-splitting rules vary, as well as legal conclusions cannot be inferred from a presentation deck.

Valuation, earnings, as well as the cash at closing

Buyers often discuss adjusted EBITDA, a measure of earnings before interest, taxes, depreciation, as well as amortization adjusted for selected items. For a physician-owned group, reported owner compensation, personal expenses, rent, recruiting costs, call coverage, as well as one-time expenses can materially affect the adjustment bridge. “Normalized” earnings should be reconciled to tax returns, general ledger, bank activity, payroll, as well as payer collections. Each adjustment should identify the amount, evidence, as well as whether it is genuinely nonrecurring or will continue after closing in another form.

Enterprise value is not the same as proceeds to owners. A simplified bridge starts with enterprise value, then subtracts debt, debt-like items, transaction expenses, and other agreed deductions, and adjusts for working capital and cash to reach equity value. The allocation among owners may also reflect ownership percentages, preferred rights, escrow, indemnity holdbacks, seller notes, and rollover. A high headline multiple can produce modest cash at closing if debt or deductions are substantial. The purchase agreement’s definitions and closing statement mechanics determine the actual result.

Illustrative example: assume an illustrative practice has $4 million of adjusted EBITDA and the buyer applies an illustrative 8x multiple, producing illustrative enterprise value of $32 million. If illustrative debt and debt-like items total $3 million, illustrative fees and expenses are $1 million, and illustrative working capital adjustment is negative $500,000, the illustrative equity value before escrow and rollover is $27.5 million. If 20% of that amount is rolled over and 10% is held in escrow, then illustrative cash proceeds before taxes and owner allocation are $19.25 million. These figures are solely illustrative and do not represent a market valuation, offer, forecast, or tax result.

Rollover equity and the second investment decision

Rollover equity means a seller reinvests part of the sale proceeds into equity or another security in the continuing organization. It may align owners with future value creation and provide a share of proceeds in a later sale. It is not equivalent to cash, and its value is uncertain until a liquidity event and distribution. The security may be common equity, preferred equity, profits interests, or another instrument, each with different rights and economics.

Owners should request a fully diluted capitalization table and a distribution waterfall showing what happens at several sale values. The waterfall should account for preferred returns, investor capital, management incentives, transaction costs, debt, as well as any other senior claims. A projected “multiple on rollover” can be misleading if it ignores dilution or assumes an exit valuation without considering negotiating strength and the time value of money. Ask how future add-on acquisitions will be funded and whether new equity can dilute existing holders, including whether participation rights exist.

Governance and liquidity rights matter as much as projected upside. Review voting rights, board representation, information access, transfer restrictions, drag-along and tag-along provisions, preemptive rights, and the ability to participate in a future sale. Understand whether an owner who leaves clinical practice must sell equity, at what price and under what formula, and who determines fair value. A repurchase provision triggered by retirement, termination, death, disability, or breach can materially change the economics. Sellers should understand the consequences before signing employment, restrictive covenant, and equity documents together.

Control after closing and owner dependence

A sale transfers some bundle of rights. The buyer may control budgets, capital allocation, acquisitions, executive appointments, and sale timing. Physicians may retain authority over diagnosis and treatment while losing influence over staffing levels, scheduling templates, office locations, service offerings, or compensation systems. Owners should translate broad assurances such as “physician-led” into the actual reserved matters, consent rights, and escalation processes in binding agreements.

Employment terms often matter more to a physician-owner’s total outcome than the purchase price alone. Review compensation methodology, productivity thresholds, call expectations, administrative duties, benefits, term, termination rights, tail coverage, restrictive covenants, and consequences of a change in control. Any transition payments or earnouts should have objective calculations, access to underlying data, a dispute procedure, and protection against buyer-controlled decisions that could prevent the target from meeting a threshold. A seller should distinguish payment for the business from compensation for future labor.

Owner dependence is also a diligence issue. If collections or referrals are concentrated among a small number of physicians, departures may reduce value or trigger purchase agreement protections. The buyer may request retention commitments, transition services, or noncompetition restrictions. Owners should identify which relationships and responsibilities can be transitioned and which remain personal to a physician. Recruitment plans and succession arrangements can strengthen negotiating credibility whether or not a transaction proceeds.

Risk allocation, diligence, as well as negotiation

Transaction documents allocate risks through representations, warranties, covenants, indemnities, escrows, as well as conditions to closing. Sellers should understand the scope and survival period of representations about billing, coding, compliance, employment, taxes, records, contracts, as well as litigation. Indemnity caps and baskets set the basic exposure. Materiality qualifiers, joint as well as several liability, fraud carve-outs, as well as escrow release mechanics determine how much of the nominal price remains exposed. Each owner should know whether obligations are individual or shared and whether they are proportional to proceeds.

Diligence should be reciprocal. Buyers will examine revenue by physician and payer, collections, denials, refunds, staffing, leases, equipment, contracts, compliance history, and claims. Owners should investigate the buyer’s fund and sponsor, financing, prior acquisitions, management team, references from sellers and employed physicians, and history of honoring contractual promises. Request clarity on who will operate the practice, which services will be centralized, and how integration costs will be paid. A polished presentation does not substitute for a committed financing plan or clear authority map.

Negotiation is not limited to price. Terms affecting control, liquidity, employment, indemnity, call coverage, real estate, and equity rights can be negotiated in parallel. A competitive process may give owners more information about value and structure, but it requires careful handling of confidential data and staff communications. Owners should agree internally on goals, decision rules, and acceptable outcomes before sharing sensitive information. A transaction should be compared with a realistic independent-practice plan, including the cost and time required to recruit, modernize systems, or add locations without a sale.

Owner implications

An owner should assess a proposal as three linked transactions: sale of an existing business, future employment or service commitments, and investment in the post-closing company. The documents, tax treatment, and risks differ across all three. Ask advisers to model cash proceeds, after-tax proceeds, rollover outcomes, and downside cases separately. A seller who needs liquidity for retirement may reasonably value cash certainty more than speculative future upside; an owner seeking continued growth may reach a different conclusion.

The practice should maintain a decision-ready record even before a buyer approaches. Reliable monthly financial statements, physician-level production and compensation data, clean contract files, documented compliance processes, and succession plans reduce uncertainty. Better records can reveal issues early and help owners distinguish a real operating improvement opportunity from a buyer’s generic synergy claim. The exercise is valuable even if owners retain the practice.

No single ownership structure guarantees better management, better economics, or worse outcomes. A well-resourced partner can solve real administrative constraints, while a poorly aligned arrangement can burden clinical entities and limit physician choice. Owners should identify their non-negotiable clinical and professional principles, then test whether proposed governance and operating procedures support them in practice.

Action checklist

• Set owner priorities: liquidity, continued clinical work, succession, growth, autonomy, as well as risk tolerance.
• Establish a complete baseline of financial statements, collections, normalized earnings, debt, working capital, leases, as well as physician-level production.
• Identify dependence on individual physicians, referral sources, payer contracts, hospitals, locations, as well as service lines.
• Obtain independent transaction counsel, tax advice, and accounting or valuation support before signing exclusivity or a letter of intent.
• Ask the buyer for its legal entity chart, ownership structure, funding sources, capitalization table, management agreement, and proposed governance rights.
• Reconcile enterprise value to cash proceeds using debt, expenses, working capital, escrow, indemnity, seller notes, and rollover assumptions.
• Model rollover outcomes through a distribution waterfall, including dilution, debt, preferred claims, management incentives, and multiple exit scenarios.
• Review the MSO agreement, fee formula, clinical authority, control of records and data, termination rights, and state-specific compliance analysis.
• Negotiate employment, call, compensation, termination, restrictive covenant, equity repurchase, and change-in-control terms as one connected package.
• Compare the proposal with a documented independent growth and succession plan; revisit the comparison before exclusivity expires.

Sources

• American Medical Association, Physician Practice Characteristics in 2024.
• American Medical Association, More physicians move to practices owned by hospitals and private equity groups.
• U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics, May 2023: Obstetricians and Gynecologists.
• Borsa et al., Expansion of Private Equity Involvement in Women’s Health Care, JAMA Internal Medicine.
• Kannan et al., Geographic Variation in Private Equity Penetration Across Select Office-Based Physician Specialties in the US, JAMA Network Open.
• American College of Obstetricians and Gynecologists, Practice Management resources.

Scope and limitations

This paper is general educational information for owners of U.S. OB-GYN practices. It is not legal, tax, accounting, investment, valuation, or clinical advice as well as does not create an advisory relationship. Public figures come from sources with different methods, populations, as well as periods; they are not directly comparable and do not describe every practice or market. Historical research identifies patterns and associations, not the outcome of an individual transaction. The illustrative calculation is hypothetical and omits taxes, transaction-specific terms, as well as other possible adjustments. Transaction structures and professional entity rules vary by state, as well as owners should obtain advice tailored to their facts as well as documents.

Questions? Contact richard@doctorsinvestorclub.com.

This material is for education only and is not a recommendation, offer, or solicitation to buy or sell any security, business, or ownership interest. Each practice owner should make independent decisions with qualified professional advisers.